Literature DB >> 30753741

Survivorship and Radiographic Analysis of Highly Porous Acetabular Cups Designed for Improved Osseointegration Potential.

Nipun Sodhi1, Anton Khlopas2, Zachary Berliner3, Kristina Dushaj1, Jon E Minter4, Brandon Naylor5, Robert Marchand6, Matthew S Hepinstall1, Michael A Mont1.   

Abstract

INTRODUCTION: A variety of highly porous materials have been used to obtain biological acetabular fixation after total hip arthroplasty (THA). Due to their improved surface-coated properties, new highly porous titanium metal implants have shown potential to promote prosthesis osseointegration. Therefore, the purpose of this multicenter study was to evaluate: 1) overall acetabular cup survivorship; 2) postoperative complications; and 3) radiographic signs of loosening and radiolucencies in patients who received a new highly porous titanium metal cup.
MATERIALS AND METHODS: A total of 81 patients who underwent primary THA and received a new porous acetabular cup between May 16, 2013 and January 27, 2016 at three academic centers were included for analysis. There were 40 women (49%) and 41 men (51%) who had a mean age of 65 years (range, 38 to 95 years) and a mean body mass index (BMI) of 28 kg/m2 (range, 16 to 43 kg/m2). The minimum follow up time was two years and seven months (range, 2 to 4 years). The cup was engineered with fully interconnected porosity designed for potential long-term biologic fixation. Medical records were reviewed to assess for any revision surgeries and postoperative complications, and the most recent radiographs were reviewed for signs of loosening or radiolucencies.
RESULTS: Overall, acetabular component survivorship, free of fixation failure or aseptic loosening, was 100%. Two patients underwent revision due to dislocations; however, revisions were performed because no constrained or dual mobility liners were available for the shell at the time. Both patients had successful outcomes and were doing well at final follow up with no further episodes of dislocation. There was one open reduction internal fixation for a periprosthetic femoral fracture, and three polyethylene revisions were performed for instability. In all of these cases, the acetabular cup was retained. On radiographic evaluation of antero-posterior pelvis radiographs, there was one patient who had radiolucencies of <1mm in Zone 1 and Zone 2 at 15 months after surgery, and another patient demonstrated radiolucencies of <1mm in Zone 2 and 3 at one-year follow up. At a minimum of two-year follow up, both patients had non-progressive and stable findings.
CONCLUSION: The results of this study demonstrated excellent survivorship, and there were no radiographic failures of this acetabular cup in primary total hip arthroplasty patients. Although two patients were found to have minimal (<1mm) radiolucencies, these were not progressive. Longer follow-up studies are needed to further assess the survivorship and outcomes of this new acetabular cup; however, based on the results of this study, these are expected to be favorable.

Entities:  

Mesh:

Year:  2019        PMID: 30753741

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  3 in total

1.  Minimum 2-Year Outcomes of a Novel 3D-printed Fully Porous Titanium Acetabular Shell in Revision Total Hip Arthroplasty.

Authors:  Elyse J Berlinberg; J Abraham Kavian; Mackenzie A Roof; Ittai Shichman; Brett Frykberg; William B Lutes; Erik A Schnaser; Stephen A Jones; Richard W McCalden; Ran Schwarzkopf
Journal:  Arthroplast Today       Date:  2022-10-12

2.  Impact of Acetabular Implant Design on Aseptic Failure in Total Hip Arthroplasty.

Authors:  Gloria Coden; Chelsea Matzko; Shazaan Hushmendy; William Macaulay; Matthew Hepinstall
Journal:  Arthroplast Today       Date:  2021-01-07

3.  Evaluation of the bone morphology around four types of porous metal implants placed in distal femur of ovariectomized rats.

Authors:  Stanislav Bondarenko; Nataliya Ashukina; Valentyna Maltseva; Gennadiy Ivanov; Ahmed Amine Badnaoui; Ran Schwarzkopf
Journal:  J Orthop Surg Res       Date:  2020-08-03       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.